Richa Dua

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

Michael Wang, Simon Rule, Pier Luigi Zinzani et al. · The Lancet · 2017 · 448 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Determinants of stunting, wasting, and underweight in five high-burden pockets of four Indian states

Praveen Kumar, RajeshKumar Sinha, Richa Dua et al. · Indian Journal of Community Medicine · 2018 · 82 citations · Full text

Public Health, Nutrition, Public Health Nutrition +17

A12 The SHP2 Inhibitor RMC-4630 in Patients with KRAS-Mutant Non-Small Cell Lung Cancer: Preliminary Evaluation of a First-in-Man Phase 1 Clinical Trial

Sai‐Hong Ignatius Ou, Marianna Koczywas, Susanna V. Ulahannan et al. · Journal of Thoracic Oncology · 2020 · 74 citations

Medicine, Oncology, Pharmacology +11

Abstract PR014: Preliminary safety and anti-tumor activity of RMC-6291, a first-in-class, tri-complex KRASG12C(ON) inhibitor, in patients with or without prior KRASG12C(OFF) inhibitor treatment

Pasi A. Jänne, Frédéric Bigot, Kyriakos P. Papadopoulos et al. · Molecular Cancer Therapeutics · 2023 · 56 citations

Medicine, Oncology, Pharmacology +15

Role of broad‐spectrum sunscreen alone in the improvement of melasma area severity index (MASI) and Melasma Quality of Life Index in melasma

Rashmi Sarkar, Sneha Ghunawat, Isha Narang et al. · Journal of Cosmetic Dermatology · 2019 · 53 citations

Medicine, Dermatology, Pharmacotherapy +11